"I look forward to the establishnt of the dical Science Center and hope that it will develop into a world-influential center that integrates scientific research, education, and exchange."
After dealing with the dia at the press conference, Zhao Yi went to the Biodical Research Institute, where he discussed the research issues of 2-CV Bing Hydrogen Molecule drugs and Tianqing Molecules with the staff.
Recently, there has been a lot of talk about the 2-CV Bing Hydrogen Molecule, mainly because Wucheng Pharmaceutical Factory has applied for drug approval. The approval process will definitely take a long ti, with the fastest estimation being more than half a year. However, as the issue has received widespread attention, news is occasionally reported by the dia.
One piece of treatnt-related news caught the attention of many people.
Wucheng Pharmaceutical Factory announced the experintal treatnt results of the 2-CV Bing Hydrogen Molecule drug. Out of seven volunteers who persisted with the injections, six had their conditions controlled, while one suffered from a severe sudden death.
anwhile, the condition of two patients improved, showing a certain increase in the regular immune ability index after using antiviral drugs.
The official dical statent of Wucheng Pharmaceutical Factory on the treatnt outco is, "The 2-CV Bing Hydrogen Molecule effectively inhibits the spread of AIDS in human blood and the central nervous system."
At first glance, the news may not seem significant, but upon further thought, it’s quite extraordinary.
All seven AIDS volunteers who received the 2-CV Bing Hydrogen Molecule treatnt were in the late stages of the disease, when various illnesses were erupting. It can be said that they reached an "incurable" stage. It is not surprising that one person died out of the seven. The fact that the immune index of two AIDS patients increased also proves the effectiveness of the 2-CV Bing Hydrogen Molecule.
Although the increased immune index may be due to "antiviral drugs," most antiviral drugs have virtually no effect on patients with advanced AIDS.
The international community also praises the effectiveness of the 2-CV Bing Hydrogen Molecule drug. One major reason is that it is a public achievent without a patent issue, which allows other pharmaceutical manufacturers to produce related drugs.
Next up are the "Tianqing Molecules."
There is relatively little news about "Tianqing Molecules", and there’s no news about their drug developnt. The news that does erge relates to Wucheng Pharmaceutical Factory cooperating with international and dostic dical institutions, providing "Tianqing Molecules" for research purposes.
Three foreign "dical institutions" have successfully obtained "Tianqing Molecules."
The number of dostic cooperative research institutions is relatively larger, with more than a dozen dical research institutions obtaining "Tianqing Molecules." As soon as a cooperation agreent is signed, the representative will get the "Tianqing Molecules" for research.
The reason for this is probably that dostic dical research institutions mostly operate within the sa system as Wucheng Pharmaceutical Factory under the supervision of higher authorities, without much problem.
There is no shortage of dissatisfaction in foreign public opinion. For instance, several dical institutions in Europe and the United States hope that Wucheng Pharmaceutical Factory will provide mutated Escherichia coli; otherwise, their research has no aning. As the mutated Escherichia coli is controlled by Wucheng Pharmaceutical Factory, any drug efficacy they research will ultimately benefit Wucheng Pharmaceutical Factory.
"Although there are no related businesses on the market, confird news proves that Tianqing Protein has a good effect against HIV. Combined with the 2CV-Bing Hydrogen Molecule and other anti-AIDS drugs, it may be possible to achieve a cure for AIDS."
"However, everything is in the hands of Wucheng Pharmaceutical Factory!"
"This is a monopoly!"
"The monopoly on the fight against major diseases for all mankind is a naked act of capital exploitation..."
"Drug patents internationally have a ti limit, and drug manufacturing materials are the sa. Wucheng Pharmaceutical Factory should provide an exact tiline for providing the mutated Escherichia coli."
Of course, that’s impossible, at least not for now!
Although the international voice has so rit, drug patent years generally range from 7 to 10 years; after that, other pharmaceutical manufacturers can replicate the sa drug.
This 7 to 10 years ti fra allows pharmaceutical manufacturers to recover their R&D costs and make so profit.
However, there are no regulations that require drug manufacturers to share their production materials, nor is there a real way to regulate it.
Before recovering R&D funds and earning the deserved profits, Wucheng Pharmaceutical Factory will definitely not provide the mutated Escherichia coli. However, a tiline can still be developed.
For example, 10 or 20 years after the drug goes on the market.
This tifra is sufficient for AIDS patients with economic ability to receive treatnt, but not enough to bring considerable profits for those without economic ability.
What happens next will depend on the situation.
Everything is changing.
All of this has little to do with Zhao Yi.
Although he receives part of the patent royalties from "Tianqing Protein," he has no decision-making power on the mutated Escherichia coli issue. Thinking about it would be a pure waste of brain cells.
Zhao Yi is more concerned about the progress of laboratory projects. There are several small projects, including Liu Chengjie’s, Yan Yi’s, and Zhang Wei’s, which need genuine attention. Firstly, as a researcher, it is his responsibility to help the mbers of the laboratory with their projects, and secondly, small projects make the laboratory’s project numbers look slightly better.
Finally, after leaving the Biodical Research Institute, it was already approaching noon. Zhao Yi went for lunch and returned to his dormitory to receive a surprising invitation.
Reviews
All reviews (0)